GlassScriptPhysician profile
James M Bensler
NPI 1457591570
$64,173.15
in general payments reported to CMS, 2019-2025
25 companies · $2,196 in 2025
The $2,196 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $3,946 · 2021: $8,308 · 2022: $13K · 2023: $4,348 · 2024: $4,430 · 2025: $2,196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,500 · Food and Beverage: $2,204 · Travel and Lodging: $1,251 · Education: $19.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,500.00 |
| Food and Beverage | $2,204.35 |
| Travel and Lodging | $1,250.60 |
| Education | $19.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42,115.69 | 2019-2024 | Lifevest |
| Pfizer INC. | $9,424.11 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $5,573.57 | 2019-2022 | |
| Medtronic, INC. | $2,647.67 | 2021-2025 | Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan, Micra |
| Medtronic Vascular, INC. | $1,179.58 | 2019-2020 | |
| Abbott Laboratories | $645.60 | 2020-2025 | Ensite, Amplatzer Amulet, Agilis |
| Atricure, INC. | $608.05 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $437.78 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $334.30 | 2020-2025 | Rhythmia Mapping System, Metriq Foot Switch, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $222.33 | 2019-2021 | |
| Biotronik INC. | $166.10 | 2023 | Edora 8 Dr-T, Acticor 7 Vr-T Dx, Solia |
| Kestra Medical Technology Services, INC. | $161.09 | 2025 | Assure Wcd |
| Lantheus Medical Imaging, INC. | $119.59 | 2019 | |
| Zoll Medical Corporation | $114.59 | 2025 | Defibrillator |
| Janssen Pharmaceuticals, INC | $76.90 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $53.95 | 2020 | |
| Irhythm Technologies, INC. | $43.08 | 2019-2024 | Zio Monitor, Zio Xt Patch |
| Akcea Therapeutics, INC. | $42.30 | 2019-2020 | |
| Amgen INC. | $41.90 | 2019 | |
| Biosense Webster, INC. | $40.80 | 2025 | Carto 3 |
| Sanofi-Aventis U.S. LLC | $29.50 | 2019 | |
| Merck Sharp & Dohme LLC | $28.37 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $25.34 | 2021-2022 | |
| Cardiva Medical, INC. | $24.76 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Davol INC. | $16.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bensler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.